Indication

Diffuse Large B-cell Lymphoma Refractory

1 clinical trial

1 drug

Clinical trial

Golcadomide (BMS-986369) Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Status: Not yet recruiting, Estimated PCD: 2026-01-15

Drug